000 01400 a2200397 4500
005 20250517091112.0
264 0 _c20171023
008 201710s 0 0 eng d
022 _a1476-5381
024 7 _a10.1111/bph.13495
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSingh, Neetu
245 0 0 _aInhibition of fatty acid synthase is protective in pulmonary hypertension.
_h[electronic resource]
260 _bBritish journal of pharmacology
_c06 2016
300 _a2030-45 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _a4-Butyrolactone
_xadministration & dosage
650 0 4 _aAnimals
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCells, Cultured
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aEnzyme Inhibitors
_xadministration & dosage
650 0 4 _aFatty Acid Synthases
_xantagonists & inhibitors
650 0 4 _aHumans
650 0 4 _aHypertension, Pulmonary
_xenzymology
650 0 4 _aMale
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aStructure-Activity Relationship
700 1 _aManhas, Amit
700 1 _aKaur, Gurpreet
700 1 _aJagavelu, Kumaravelu
700 1 _aHanif, Kashif
773 0 _tBritish journal of pharmacology
_gvol. 173
_gno. 12
_gp. 2030-45
856 4 0 _uhttps://doi.org/10.1111/bph.13495
_zAvailable from publisher's website
999 _c25908842
_d25908842